Research Summary
Analyzed using Evidence Intelligence™

Curcuma longa extract improves neuropathy symptoms in type 2 diabetes

Key finding

CLE supplementation resulted in a significant reduction in neuropathy symptom score compared with placebo (P = 0.048).

This study evaluated the effects of Curcuma longa extract on neuropathy symptoms and vascular biomarkers in adults with type 2 diabetes, finding significant improvements in several measures.

Evidence strength

Moderate confidence

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Some Concerns bias
Last updated July 5, 2026

Quick read

Study at a glance

The essential study design details in one scan.

Population

Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes

Intervention

Curcuma longa extract (CLE)

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Primary outcome

Neuropathy symptom score

Comparator

Placebo group

Plain-language summary

What this paper says

A plain-language read of the study's main message and where it applies.

Study focus

This study evaluated the effects of Curcuma longa extract on neuropathy symptoms and vascular biomarkers in adults with type 2 diabetes, finding significant improvements in several measures.

Clinical relevance

These findings suggest that Curcuma longa extract could be a beneficial supplement for adults with type 2 diabetes, potentially improving their quality of life by alleviating neuropathy symptoms and reducing inflammation, which are common complications of the disease.

Keep in mind

The study may have limited generalizability due to a specific participant demographic. The sample size and duration of the study may not capture long-term effects. Potential biases in self-reported outcomes could affect the reliability of symptom scores.

Published in

Journal Reference

Publication details and source links for this paper.

Drielly RV, Alanna RM, Cristina AS, Maria DCF. Effects of Curcuma longa extract supplementation on vascular, redox-inflammatory biomarkers, and neuropathy symptoms in adults with type 2 diabetes mellitus: A randomized double-blind placebo-controlled trial. European Journal of Nutrition. 2026;65(3):116. doi:10.1007/s00394-026-03963-3

Save this study and add notes to your research library.

Main Effects

Curcuma longa extract reduced neuropathy symptom score by 1.5 points (P = 0.048).

Curcuma longa extract significantly decreased Syndecan-1 levels by 46.5 ng/mL (P = 0.001).

Curcuma longa extract significantly reduced Hyaluronic acid levels by 68.1 ng/mL (P = 0.002).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Curcuma longa extract (CLE) and Hyaluronic acid (HA), Matrix metalloproteinase-2 (MMP-2), Matrix metalloproteinase-9 (MMP-9), and 8 more.

Primary intervention

Curcuma longa extract (CLE)

Primary outcomes

  • Hyaluronic acid (HA)
  • Matrix metalloproteinase-2 (MMP-2)
  • Matrix metalloproteinase-9 (MMP-9)

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

11
Evidence pairs
11
Relationships
0
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 54

0

Related topics

11

Evidence pairs

0

Related studies

Why it is useful

  • Contributes to 11 evidence relationships
  • Includes primary outcome data
  • Linked to 0 direct semantic evidence topics

Core evidence

Study findings

The primary outcomes reported in this study.

StrongDecrease

Hyaluronic acid (HA)

Curcuma longa extract (CLE) → Hyaluronic acid (HA)

Curcuma longa extract (CLE) → Hyaluronic acid (HA)

Evidence profile

StrongDecreaseClinical Outcomes
Unlock full evidence details
StrongDecrease

Matrix metalloproteinase-2 (MMP-2)

Curcuma longa extract (CLE) → Matrix metalloproteinase-2 (MMP-2)

Curcuma longa extract (CLE) → Matrix metalloproteinase-2 (MMP-2)

Evidence profile

StrongDecreaseClinical Outcomes
Unlock full evidence details
StrongDecrease

Matrix metalloproteinase-9 (MMP-9)

Curcuma longa extract (CLE) → Matrix metalloproteinase-9 (MMP-9)

Curcuma longa extract (CLE) → Matrix metalloproteinase-9 (MMP-9)

Evidence profile

StrongDecreaseClinical Outcomes
Unlock full evidence details
StrongDecrease

Neuropathy symptom score

Curcuma longa extract (CLE) → Neuropathy symptom score

Curcuma longa extract (CLE) → Neuropathy symptom score

Evidence profile

StrongDecreaseClinical Outcomes
Unlock full evidence details
StrongIncrease

Nuclear factor erythroid 2-related factor 2 (Nrf2)

Curcuma longa extract (CLE) → Nuclear factor erythroid 2-related factor 2 (Nrf2)

Curcuma longa extract (CLE) → Nuclear factor erythroid 2-related factor 2 (Nrf2)

Evidence profile

StrongIncreaseMetabolic Health
Unlock full evidence details
StrongDecrease

Nuclear factor kappa B (NF-κB p65)

Curcuma longa extract (CLE) → Nuclear factor kappa B (NF-κB p65)

Curcuma longa extract (CLE) → Nuclear factor kappa B (NF-κB p65)

Evidence profile

StrongDecreaseMetabolic Health
Unlock full evidence details
StrongIncrease

Sirtuin-1 (SIRT1)

Curcuma longa extract (CLE) → Sirtuin-1 (SIRT1)

Curcuma longa extract (CLE) → Sirtuin-1 (SIRT1)

Evidence profile

StrongIncreaseClinical Outcomes
Unlock full evidence details
StrongDecrease

Syndecan-1 (SDC1)

Curcuma longa extract (CLE) → Syndecan-1 (SDC1)

Curcuma longa extract (CLE) → Syndecan-1 (SDC1)

Evidence profile

StrongDecreaseClinical Outcomes
Unlock full evidence details
StrongDecrease

Syndecan-4 (SDC4)

Curcuma longa extract (CLE) → Syndecan-4 (SDC4)

Curcuma longa extract (CLE) → Syndecan-4 (SDC4)

Evidence profile

StrongDecreaseClinical Outcomes
Unlock full evidence details
StrongIncrease

Thioredoxin-1 (Trx1)

Curcuma longa extract (CLE) → Thioredoxin-1 (Trx1)

Curcuma longa extract (CLE) → Thioredoxin-1 (Trx1)

Evidence profile

StrongIncreaseClinical Outcomes
Unlock full evidence details
StrongDecrease

Thioredoxin-binding protein-2 (TBP2)

Curcuma longa extract (CLE) → Thioredoxin-binding protein-2 (TBP2)

Curcuma longa extract (CLE) → Thioredoxin-binding protein-2 (TBP2)

Evidence profile

StrongDecreaseClinical Outcomes
Unlock full evidence details

Unlock full evidence analysis

Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.

evidence suggest

Evidence Suggest

  • Curcuma longa extract reduced Syndecan-4 levels by 46 pg/mL (P = 0.040).
  • Curcuma longa extract reduced Matrix metalloproteinase-2 levels by 34.9 ng/mL (P < 0.001).
  • Curcuma longa extract increased Thioredoxin-1 levels (all P < 0.05).
who this applies

Who this applies to

  • Adults diagnosed with type 2 diabetes.
  • Individuals experiencing neuropathy symptoms related to diabetes.
keep in mind

Keep in Mind

  • Results may not apply to all populations, as the study had specific inclusion criteria.
  • Further research is needed to confirm long-term effects and safety.
  • The study did not assess potential interactions with other diabetes medications.
between the lines

Between the Lines

  • The study may have limited generalizability due to a specific participant demographic.
  • The sample size and duration of the study may not capture long-term effects.
  • Potential biases in self-reported outcomes could affect the reliability of symptom scores.

Unlock Full Analysis

Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.

Already have an account?

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Curcuma longa extract (CLE) and Hyaluronic acid (HA), Curcuma longa extract (CLE) and Matrix metalloproteinase-2 (MMP-2).

Related evidence relationships

Explore in Evidence Archive

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Curcuma longa extract (CLE) improve hyaluronic acid (ha)?

Emerging Evidence

Curcuma longa extract (CLE) appears to improve Hyaluronic acid (HA).

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Hyaluronic acid (HA)

    EvidenceScore™ Emerging | EvidenceScore™ 54.5 | strong positive | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Curcuma longa extract (CLE) improve matrix metalloproteinase-2 (mmp-2)?

Emerging Evidence

Curcuma longa extract (CLE) appears to improve Matrix metalloproteinase-2 (MMP-2).

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Matrix metalloproteinase-2 (MMP-2)

    EvidenceScore™ Emerging | EvidenceScore™ 54.5 | strong positive | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Curcuma longa extract (CLE) improve matrix metalloproteinase-9 (mmp-9)?

Emerging Evidence

Curcuma longa extract (CLE) appears to improve Matrix metalloproteinase-9 (MMP-9).

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Matrix metalloproteinase-9 (MMP-9)

    EvidenceScore™ Emerging | EvidenceScore™ 54.5 | strong positive | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Curcuma longa extract (CLE) improve neuropathy symptom score?

Emerging Evidence

Curcuma longa extract (CLE) appears to improve Neuropathy symptom score.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Neuropathy symptom score

    EvidenceScore™ Emerging | EvidenceScore™ 54.5 | strong positive | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, archive views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.